Megan Liles

Nov 21, 2024 | clinicalleader.com | Lella Baker |Megan Liles |Ben Edwards |Liz Hawes

Right-sized for biotech successIt's not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We've got you. The Benefits Of The New ICH M11 GuidelineWith 25 years of global data science experience, Jessica Jolly gives a quick overview of the ICH M11 guideline and talks about some specifics of its two pillars: standardization and automation.

Oct 25, 2024 | clinicalleader.com | Megan Liles

By Megan Liles, founder, Liles Clinical Trials The clinical research industry is, if anything, predictable. Among other things, we are slow to adopt new ways of doing things, a little wary of using technology, and still heavily dependent on Excel-based trackers. And, we have a curious habit with in-sourcing and outsourcing.

Apr 8, 2024 | clinicalleader.com | Megan Liles

By Megan Liles, principal, Liles Clinical Trials Consulting It was only a few years ago that in early phase clinical trials, particularly in oncology, vendor management consisted of…. well, an EDC system, maybe a central IRB, central imaging (for collecting and holding scans), and then some pharmacokinetic or biomarker analyses done at bioanalytical labs. But really, everything else was done at the sites.